International

Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Elemental Altus Royalties Corp. (TSXV: ELE) (OTCQX: ELEMF) (“Elemental Altus” or the “Company“) is pleased to announce the creation of a cornerstone gold royalty at Laverton in Western Australia. The Laverton royalty acquisition builds on the Company’s existing coverage to create a cornerstone gold …

Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) (“Great Pacific Gold,” “GPAC,” or the “Company”) announces results from its recently expanded Phase 1 diamond drill program at its flagship Wild Dog Project (“Wild Dog” or the “Project”), located on …

Toronto, Ontario–(Newsfile Corp. – September 2, 2025) – ONGold Resources Ltd. (TSXV: ONAU) (OTCQB: ONGRF) (“ONGold“) is pleased to announce that the company has initiated an infill sampling program targeting intervals not previously sampled for tungsten and gold throughout the Monument Bay deposit (“Monument Bay“) where tungsten could add a significant gold …

Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunity Patrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to …

Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Lara Exploration Ltd. (TSXV: LRA) (“Lara” or the “Company”) is pleased to report that it has signed a binding letter of intent with a non-reporting Ontario company (the “Optionee”), to fund further exploration and development of Lara’s Itaituba Vanadium Project (the “Project”), located …

Moncton, New Brunswick and Boston, Massachusetts–(Newsfile Corp. – September 2, 2025) – Soricimed Biopharma Inc. (“Soricimed”), a clinical-stage biopharmaceutical company focused on developing precision oncology drugs, today announced the appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer (CSO). This strategic addition underscores Soricimed’s commitment to advancing its TRPV6-targeting …

Strategic Partnership with Brazilian Iron Ore Processor Accelerates Path to Cash Flow Belo Horizonte, Brazil–(Newsfile Corp. – September 2, 2025) – Atlas Critical Minerals Corporation (OTCQB: JUPGF) (“Atlas Critical Minerals” or the “Company”) is pleased to report that its Iron Quadrangle Project (“Project”) expects to generate initial revenues in the …

Toronto, Ontario–(Newsfile Corp. – September 2, 2025) – Dexterra Group Inc. (TSX: DXT) (“Dexterra” or the “Company”) is pleased to announce the successful closure of the previously disclosed acquisition of Right Choice Camps & Catering (“Right Choice”) effective August 31, 2025. “We are excited to welcome Right Choice to Dexterra,” said …

Company on track to begin submission of a rolling Biologics Licensing Application (BLA) request for OST-HER2 to U.S. Food & Drug Administration in September 2025 New York, New York–(Newsfile Corp. – September 2, 2025) – OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy …

Toronto, Ontario–(Newsfile Corp. – September 2, 2025) – Volta Metals Ltd. (CSE: VLTA) (FSE: D0W) (“Volta” or the “Company“) is pleased to announce the closing of an oversubscribed non-brokered private placement for gross proceeds of $1,545,300 (the “Offering“). The Offering was comprised of the issuance of: (i) 8,441,250 units of …